J&J vaccine effective against COVID Delta variant, drugmaker says
By
Alicia Lasek
Jul 06, 2021
Johnson & Johnson’s single-shot COVID-19 vaccine prompts a “strong neutralizing antibody response” that lasts at least eight months, the drugmaker has announced.
FDA: Evusheld may be less effective against latest COVID variants
By
Alicia Lasek
Oct 05, 2022
Evusheld, a preventive COVID-19 antibody for high-risk patients, may lose efficacy in the face of newly emerging variants, the FDA has informed clinicians.
Study highlights nurses’ sleep challenges during pandemic
By
Alicia Lasek
Jan 28, 2022
Nurses have lost a lot of sleep during the COVID-19 pandemic, and their sleep problems are closely tied to mental health issues that can affect well-being, a new investigation finds.